KLRC2 and leukemia: These adaptive NKG2C+ NK cells exhibit higher effector functions than canonical NKG2C− NK cells and have been associated with the control of HCMV infection in kidney transplant recipients and with protection from leukemia relapse after allogeneic hematopoietic stem cell transplantation (HSCT) (17, 19–24).